Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleCommon kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G‐CSF based regimens.AuthorsSenapati, Jayastu; Abuasab, Tareq; Haddad, Fadi G.; Ravandi, Farhad; Kadia, Tapan; DiNardo, Courtney; Daver, Naval; Pemmaraju, Naveen; Alvarado, Yesid; Brandt, Mark A.; Kantarjian, Hagop; Borthakur, GautamPublicationAmerican Journal of Hematology, 2023, Vol 98, Issue 3, pE53ISSN0361-8609Publication typeArticleDOI10.1002/ajh.26811